States scrambling to buy Covid-19 vaccines directly from foreign manufacturers - to boost what they say is insufficient supply from the centre - seem to be running into a roadblock in some cases. At least two pharmaceutical giants have refused to sell them to the states. American companies Pfizer & Moderna have turned down requests to supply Delhi and Punjab with their vaccines. Both cited official policy and said they would only deal with the centre. The company also said discussions with the centre - to roll out its vaccine in India - were "ongoing". Emergency use approval for the drug has been held up, news agency Reuters reported last week, over Pfizer's demands for legal indemnity from claims linked to its product. Moderna is understood to have made similar demands for legal protection. Vaccine supplies have become a sore subject in India, with several states insisting they do not have enough doses to vaccinate both age groups - 18-44 and 45+ - but the centre insisting they do. The result has been some states shutting down vaccination centres or suspending inoculation for the 18-44 demographic. Watch the video to know more.
Google Trends